Purchase Order AG9135P10AA01179

<p>The NIH Clinical Center awarded a purchase order to Agilent Technologies Inc. for $7,550.07 on May 17, 2016, for a Low Input QuickAmp Labeling Kit, with final delivery by May 31, 2016. The order is firm fixed price with no set-aside designation. Performance takes place in Bethesda, Maryland. This is a commercial laboratory consumable supporting research operations at the NIH Clinical Center.</p>

<p>The National Cancer Institute issued a purchase order to The Johns Hopkins University on September 3, 2015, for combined RNA and DNA isolation from frozen PBMC vials, including DNase treatment for RNA samples and quality control for both DNA and RNA, with a ceiling value of $11,340.00. Work was performed in Baltimore, Maryland. The order carried firm fixed price terms and was not set-aside. The ultimate completion date was February 14, 2020.</p>

Tecan Genomics Inc. has been awarded a firm fixed-price purchase order valued at fifteen thousand seven hundred twenty-three dollars by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNA sequencing services. Specifically, the prime contractor will deliver universal plus total RNA sequencing with NuQuant human any deplete analysis for the NIH's infectious disease programs. Performance will take place in Redwood City, California over a four...

This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V., for $14,921.70. The contract is for library preparation items needed for next-generation sequencing assays for NIH Clinical Center patients. The order has a completion date of November 23, 2024. Qiagen is an international provider of sample and assay technologies that has previously provided DNA/RNA extraction kits, next-generation sequencing,...

This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Qiagen, LLC, a division of Qiagen N.V., for RNA quantitative analysis services. The award has a ceiling value of $13,390.28 and a completion date of February 7, 2022. Qiagen, LLC is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academic research. The company has extensive experience supporting federal agencies such as...

This firm-fixed-price purchase order was awarded to Qiagen, LLC by the Centers for Disease Control and Prevention (CDC) to provide next-generation sequencing of pulmonary microRNA. The $24,994.80 contract has a performance period ending on September 30, 2023. Qiagen, a division of the parent company Qiagen N.V., is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. The company has a history of providing a range of goods...

This purchase order award from the Department of Health and Human Services' National Institutes of Health Clinical Center to Qiagen, LLC is for $10,847.20 to support library preparation in next generation sequencing assays for clinical center patients. Qiagen will provide products and services for DNA/RNA extraction and sample preparation to support the agency's biomedical research and public health programs. As an international provider of molecular diagnostics technologies, Qiagen has...

Qiagen, LLC was awarded a contract by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) on April 14, 2015, to provide RNA isolation and quantitative polymerase chain reaction (qPCR) services for 154 biological samples. The contract, issued as a Blanket Purchase Agreement (BPA) call under a firm fixed-price arrangement, has a ceiling value of approximately $14.9K and was set to conclude on April 30, 2024. The work will be performed in Valencia, California. As a BPA call, this...

This standing order contract was awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development to Lofstrand Labs LTD. Under the terms of the firm fixed price contract valued at approximately $9,848, the prime contractor will provide radioactive labeling service, oligonucleotide synthesis and purification, low throughput DNA sequencing service and shipping for labeling and sequencing as requested in individual...

<p>The National Human Genome Research Institute awarded a purchase order to Tecan Genomics, Inc. for $23,019.00 on April 2, 2021, for universal RNA-seq with NuQuant and UDI, Drosophila AnyDeplete. Work is performed at North Bethesda, Maryland. The order is firm fixed-price with no set-aside designation and an ultimate completion date of April 2, 2021.</p>